Biologics Fill / Finish Services Market, 2019 - 2030

Report
483 Pages
May 2019
Region: Global
Roots Analysis
ID: 4806515

Biologics constitute a majority of the top-selling drugs and presently represent one of the fastest-growing segments of the overall pharmaceutical industry. In fact, since the launch of recombinant protein-based therapies around three decades earlier, the overall biologics market has grown at an annualized rate of over 12%. It is also worth highlighting that more than 5,000 biopharmaceutical product candidates are currently under development. Despite the fact that biopharmaceuticals offer significant profit margins, the sponsors of such pharmacological interventions are plagued by high costs of development and complex production protocols. As a result, several start-ups / small-sized companies and certain pharma giants have begun outsourcing different aspects of their business operations to contract service providers. According to the 2017 Nice Insight CDMO survey, about 54% of 700 respondents claimed to have collaborated with a contract service provider for clinical and commercial-scale product development projects. Contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) are known to offer significant benefits, such as the reduction in capital investment, access to larger production capacities, reductions in time-to-market and reduced commercialization risk.

Specifically, fill/finish is the final step in the production process and is considered among the most crucial stages of drug product manufacturing. Biologics drug products require special procedures and equipment for fill/finish operations in order to ensure product integrity and safety. As this operation is heavily outsourced, the rise in demand for biologics has resulted in an equivalent need for flexible aseptic fill/finish technologies. Pharmaceutical drug manufacturers have not hesitated to collaborate with contract service providers to leverage the latter’s experience and expertise in the latest fill/finish technologies. Currently, over 115 companies are actively providing fill/finish services for biologics. In the recent past, many service providers have also forged alliances / acquired other players in order to enhance their service offerings.

Scope of the Report

The ‘Biologics Fill / Finish Service Providers, 2019-2030’ report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill/finish operations. Amongst other elements, the report includes:

A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals, featuring a list of active service providers and detailed analysis based on a number of relevant parameters, such as scale of operation (preclinical, clinical and commercial), type of biologics filled (peptides / proteins, antibodies, vaccines, cell therapies, gene therapies, viral products, oligonucleotides and others), year of establishment, company size and geographical location of the service provider, count and location of affiliated fill / finish facilities, number of additional services offered (lyophilization, labelling, quality testing, storage and distribution services), dosage forms handled (liquid and lyophilized), and types of primary packaging containers handled (ampoules, cartridges, syringes and vials), including details on fill / finish capacity and fill volume range.
A region-wise, company competitiveness analysis, highlighting prominent fill/finish service providers across various packaging types, based on supplier strength (considering experience and company size of the service provider), service strength (considering number of fill / finish facilities, number of continents where the aforementioned facilities are located, number of additional services offered and scale of operation) and types of biologics handled.
Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific), which were shortlisted based on our proprietary company competitiveness analysis. Each profile provides an overview of the company, information on its overall service portfolio, fill/finish facilities, financial performance (if available), and details on partnerships, expansions and recent awards and accolades, as well as an informed future outlook.
An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics, based on various parameters, such as year of agreement, type of agreement, scale of operation of the project, focus area, types of services mentioned in the deal, types of biologics involved and location of facility where the project is to be executed.
A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios, based on a number of parameters, including year of expansion, type of expansion (capacity expansion and new facility), geographical location of facility, type of packaging container involved, scale of operation (as mentioned in the expansion terms), types of services and biologics involved, expansion details (in terms of new area added to existing facilities, if available) and most active players (in terms of number of instances).
An estimate of the global, contract fill/finish capacity, by taking into consideration the capacities of various fill/finish service providers (as available on respective company websites), collected via secondary and primary research. The study examines the distribution of number of packaging units and volume of biologics filled, across various types of packaging containers (ampoules, cartridges, syringes, and vials), based on the size of the company / organization (small-sized, mid-sized and large) and geography (North America, Europe and Asia Pacific).
An informed estimate of the annual demand for fill/finish of biologics, taking into account the top 20 biologics, based on various relevant parameters, such as target patient population, dosing frequency, dose strength, type of packaging container and volume of the packaging container of the abovementioned products.
An analysis to identify the key performance indicators for service providers active in the domain, based on information gathered via secondary research (for top-ten pharmaceutical players) and primary research.
A case study to highlight the benefits of using robotic / automated equipment for aseptic fill/finish processes; the study provides a list of equipment manufacturers providing robots suitable for pharmaceutical operations.
A case study to highlight the role of ready-to-use packaging containers in aseptic fill/finish operations; the study provides a list of suppliers providing the ready-to-use components.
A discussion on the potential growth areas, such as growing biopharmaceutical pipeline, increasing outsourcing of fill/finish operations, rising focus on self-administration enabling drug delivery devices and growing opportunities in Asia-Pacific region, which are likely to present in the coming years.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the market. Based on parameters, such as growth of the overall biopharmaceutical market, cost of goods sold, direct manufacturing costs, share of drug product manufacturing costs, and outsourcing trends related to fill / finish operations, we have provided an informed estimate of the likely evolution of the market in the mid to long term, for the period 2019-2030. Our year-wise projections of the current and future opportunity have further been segmented on the basis of [A] types of primary packaging containers used for fill / finish (ampoules, cartridges, syringes and vials), [B] types of biologics (peptides / proteins, antibodies, vaccines, cell therapies, gene therapies, viral products, oligonucleotides and others), [C] company size (small-sized, mid-sized and large / very large), [D] scale of operation (preclinical, clinical and commercial), [E] key therapeutic areas (cancer, infectious diseases, autoimmune diseases, cardiovascular diseases and other indications), and [F] key geographical regions (North America (US, Canada), Europe (UK, France, Germany, Italy, Spain and Rest of the Europe), Asia-Pacific (Japan, China, South Korea, India and Australia)). To account for the uncertainties associated with the fill/finish of biopharmaceuticals and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following industry stakeholders:

Ales Sima, Business Development Manager, oncomed manufacturing
Gregor Kawaletz, Chief Commercial Officer, IDT Biologika
Jos Vergeest, International Business Developer, HALIX
Purushottam Singnurkar, Research Director and Head of Formulation Development, Syngene International

All actual figures have been sourced and analysed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD unless otherwise specified.

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Introduction to Biologics
3.3. Need for Outsourcing Biologics-related Operations
3.4. Introduction to Contract Manufacturing
3.5. Commonly Outsourced Operations in the Biopharmaceutical Industry
3.5.1. Biologics Fill/Finish Operations
3.6. Basic Guidelines for Selecting a Fill/Finish Service Provider
3.7. Advantages of Outsourcing Fill/Finish Services
3.8. Risks and Challenges of Outsourcing Fill/Finish Operations

4. COMPETITIVE LANDSCAPE

4.1. Chapter Overview
4.2. Biologics Fill/Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Fill/Finish Facilities
4.2.5. Analysis by Type of Packaging
4.2.6. Analysis by Additional Services Offered
4.2.7. Analysis by Scale of Operation
4.2.8. Analysis by Type of Biologics Filled

5. COMPANY COMPETITIVE ANALYSIS

5.1. Chapter Overview
5.2. Methodology
5.3. Assumptions and Key Input Parameters
5.4. Competitiveness Analysis: Biologics Fill/Finish Service Providers in North America
5.4.1. Companies Offering Fill/Finish Services for Ampoules
5.4.2. Companies Offering Fill/Finish Services for Cartridges
5.4.3. Companies Offering Fill/Finish Services for Syringes
5.4.4. Companies Offering Fill/Finish Services for Vials
5.5. Competitiveness Analysis: Fill/Finish Service Providers in Europe
5.5.1. Companies Offering Fill/Finish Services for Ampoules
5.5.2. Companies Offering Fill/Finish Services for Cartridges
5.5.3. Companies Offering Fill/Finish Services for Syringes
5.5.4. Companies Offering Fill/Finish Services for Vials
5.6. Competitiveness Analysis: Fill/Finish Service Providers of Asia-Pacific
5.6.1. Companies Offering Fill/Finish Services for Ampoules
5.6.2. Companies Offering Fill/Finish Services for Cartridges
5.6.3. Companies Offering Fill/Finish Services for Syringes
5.6.4. Companies Offering Fill/Finish Services for Vials

6. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

6.1. Chapter Overview
6.2. Advanced BioScience Laboratories (ABL)
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments
6.2.4. Future Outlook
6.3. Albany Molecular Research (AMRI)
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Financial Information
6.3.4. Recent Developments
6.3.5. Future Outlook
6.4. BioPharma Solutions
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Financial Information
6.4.4. Recent Developments
6.4.5. Future Outlook
6.5. BioReliance
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Financial Information
6.5.4. Recent Developments
6.5.5. Future Outlook
6.6. Emergent BioSolutions
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Financial Information
6.6.4. Recent Developments
6.6.5. Future Outlook
6.7. Patheon
6.7.1. Company Overview
6.7.2. Services Portfolio
6.7.3. Financial Information
6.7.4. Recent Developments
6.7.5. Future Outlook

7. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES

7.1. Chapter Overview
7.2. Boehringer Ingelheim BioXcellence
7.2.1. Company Overview
7.2.2. Service Portfolio
7.2.3. Financial Information
7.2.4. Recent Developments
7.2.5. Future Outlook
7.3. IDT Biologika
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Recent Developments
7.3.4. Future Outlook
7.4. Lonza
7.4.1. Company Overview
7.4.2. Service Portfolio
7.4.3. Financial Information
7.4.4. Recent Developments
7.4.5. Future Outlook
7.5. Recipharm
7.5.1. Company Overview
7.5.2. Service Portfolio
7.5.3. Financial Information
7.5.3. Recent Developments
7.5.4. Future Outlook
7.6. Vetter Pharma
7.6.1. Company Overview
7.6.2. Service Portfolio
7.6.3. Recent Developments
7.6.4. Future Outlook

8. BIOLOGICS FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES

8.1. Chapter Overview
8.2. Biocon
8.2.1. Company Overview
8.2.2. Service Portfolio
8.2.3. Financial Information
8.2.4. Recent Developments
8.2.5. Future Outlook
8.3. ChemPartner
8.3.1. Company Overview
8.3.2. Service Portfolio
8.3.3. Recent Developments
8.3.4. Future Outlook
8.4. LuinaBio
8.4.1. Company Overview
8.4.2. Service Portfolio
8.4.3. Recent Developments
8.4.4. Future Outlook
8.5. Mycenax Biotech
8.5.1. Company Overview
8.5.2. Service Portfolio
8.5.3. Financial Information
8.5.3. Recent Developments
8.5.4. Future Outlook
8.6. Wuxi Biologics
8.6.1. Company Overview
8.6.2. Service Portfolio
8.6.3. Financial Information
8.6.4. Recent Developments
8.6.4. Future Outlook

9. PARTNERSHIPS AND COLLABORATIONS

9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Fill/Finish Service Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Type of Service
9.3.4. Analysis by Scale of Operation
9.3.5. Analysis by Type of Biologic
9.3.6. Analysis by Geographical Location
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8. Service Alliances and Supply Agreements: Analysis by Type of Service
9.3.9. Acquisitions and Mergers: Analysis by Type of Service

10. RECENT EXPANSIONS

10.1. Chapter Overview
10.2. Biologics Fill/Finish Service Providers: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Type of Packaging
10.2.4. Analysis by Type of Service
10.2.5. Analysis by Type of Biologic
10.2.6. Analysis by Type of Biologic and Scale of Operation
10.2.7. Analysis by Geographical Location
10.2.8. Most Active Players: Analysis by Type of Service and Type of Biologic
10.2.9. Expansions in North America: Analysis by Type of Service and Type of Biologic
10.2.10. Expansions in Europe: Analysis by Type of Service and Type of Biologic
10.2.11. Expansions in Asia-Pacific: Analysis by Type of Service and Type of Biologic

11. CAPACITY ANALYSIS

11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Global Biologics Fill/Finish Capacity (by Number of Units)
11.3.1. Analysis by Type of Packaging
11.3.2. Analysis by Size of Manufacturer
11.3.3. Analysis by Scale of Operation
11.3.4. Analysis by Location of Headquarters
11.3.5. Analysis by Location of Fill/Finish Facilities
11.4. Global Biologics Fill/Finish Capacity (by Volume)
11.4.1. Analysis by Type of Packaging
11.4.2. Analysis by Size of Manufacturer
11.4.3. Analysis by Scale of Operation
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Location of Fill/Finish Facilities
11.5. Global Biologics Fill/Finish Capacity: Ampoules (by Number of Units)
11.5.1 Analysis by Size of Manufacturer
11.5.2 Analysis by Scale of Operation
11.5.3. Analysis by Location of Headquarters
11.5.4 Analysis by Location of Fill/Finish Facilities
11.6. Global Biologics Fill/Finish Capacity: Ampoules (by Volume)
11.6.1. Analysis by Size of Manufacturer
11.6.2. Analysis by Scale of Operation
11.6.3. Analysis by Location of Headquarters
11.6.4. Analysis by Location of Fill/Finish Facilities
11.7. Global Biologics Fill/Finish Capacity: Cartridges (by Number of Units)
11.7.1. Analysis by Size of Manufacturer
11.7.2. Analysis by Scale of Operation
11.7.3. Analysis by Location of Headquarters
11.7.4. Analysis by Location of Fill/Finish Facilities
11.8. Global Biologics Fill/Finish Capacity: Cartridges (by Volume)
11.8.1. Analysis by Size of Manufacturer
11.8.2. Analysis by Scale of Operation
11.8.3. Analysis by Location of Headquarters
11.8.4. Analysis by Location of Fill/Finish Facilities
11.9. Global Biologics Fill/Finish Capacity: Syringes (by Number of Units)
11.9.1 Analysis by Size of Manufacturer
11.9.2 Analysis by Scale of Operation
11.9.3. Analysis by Location of Headquarters
11.9.4 Analysis by Location of Fill/Finish Facilities
11.10. Global Biologics Fill/Finish Capacity: Syringes (by Volume)
11.10.1. Analysis by Size of Manufacturer
11.10.2. Analysis by Scale of Operation
11.10.3. Analysis by Location of Headquarters
11.10.4. Analysis by Location of Fill/Finish Facilities
11.11. Global Biologics Fill/Finish Capacity: Vials (by Number of Units)
11.11.1 Analysis by Size of Manufacturer
11.11.2 Analysis by Scale of Operation
11.11.3. Analysis by Location of Headquarters
11.11.4. Analysis by Location of Fill/Finish Facilities
11.12. Global Biologics Fill/Finish Capacity: Vials (by Volume)
11.12.1. Analysis by Size of Manufacturer
11.12.2. Analysis by Scale of Operation
11.12.3. Analysis by Location of Headquarters
11.12.4. Analysis by Location of Fill/Finish Facilities
11.13. Conclusion

12. DEMAND ANALYSIS

12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Global Demand for Biologics Fill/Finish Services
12.3.1. Analysis by Type of Packaging
12.3.2. Analysis by Scale of Operation
12.3.3. Analysis by Type of Biologic
12.3.4. Analysis by Therapeutic Area
12.3.5. Analysis by Geographical Location
12.4. Demand and Supply Analysis

13. BIOLOGICS MANUFACTURING AND FILL / FINISH: KEY PERFORMANCE INDICATOR ANALYSIS

13.1. Chapter Overview
13.2. Biologics Manufacturing and Fill/Finish: KPI Definitions
13.2.1. Financial Indicators
13.2.1.1. Most Important KPIs
13.2.1.2. Industry Perspective
13.2.1.2.1. Big Pharma Perspective
13.2.1.2.2. Contract Manufacturers’ Perspective
13.2.2. Process / Capability Indicators
13.2.2.1. Most Important KPIs
13.2.2.2. Industry Perspective
13.2.2.2.1. Big Pharma Perspective
13.2.2.2.2. Contract Manufacturers’ Perspective
13.2.3. Market Reputation Indicators
13.2.3.1. Most Important KPIs
13.2.3.2. Industry Perspective
13.2.3.2.1. Big Pharma Perspective
13.2.3.2.2. Contract Manufacturers’ Perspective
13.2.4. Other Important Performance Indicators
13.3.5. Conclusion

14. MARKET SIZING AND OPPORTUNITY ANALYSIS

14.1. Chapter Overview
14.2. Forecast Methodology
14.3. Overall Biologics Contract Manufacturing Market, 2019-2030
14.4. Overall Biologics Fill/Finish Services Market, 2019-2030
14.4.1. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Type of Packaging
14.4.2. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Scale of Operation
14.4.3. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Type of Biologic
14.4.4. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Therapeutic Area
14.4.5. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Geographical Region
14.4.5.1. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Type of Packaging
14.4.5.2. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Scale of Operation
14.4.5.3. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Type of Biologic
14.4.5.4. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Therapeutic Area
14.4.5.5. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Type of Packaging
14.4.5.6. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Scale of Operation
14.4.5.7. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Type of Biologic
14.4.5.8. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Therapeutic Area
14.4.5.9. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Type of Packaging
14.4.5.10. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.4.5.11. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.4.5.12. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.5. Biologics Fill/Finish Services Market for Ampoules, 2019-2030
14.5.2. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Scale of Operation
14.5.2. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Type of Biologic
14.5.3. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Therapeutic Area
14.5.4. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Geographical Region
14.5.4.1. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Scale of Operation
14.5.4.2. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Type of Biologic
14.5.4.3. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Therapeutic Area
14.5.4.4. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Scale of Operation
14.5.4.5. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Type of Biologic
14.5.4.6. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Therapeutic Area
14.5.4.7. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.5.4.8. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.5.4.9. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.6. Biologics Fill/Finish Services Market for Cartridges, 2019-2030
14.6.1. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Scale of Operation
14.6.2. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Type of Biologic
14.6.3. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Therapeutic Area
14.6.4. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Geographical Region
14.6.4.1. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Scale of Operation
14.6.4.2. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Type of Biologic
14.6.4.3. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Therapeutic Area
14.6.4.4. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Scale of Operation
14.6.4.5. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Type of Biologic
14.6.4.6. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Therapeutic Area
14.6.4.7. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.6.4.8. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.6.4.9. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.7. Biologics Fill/Finish Services Market for Syringes, 2019-2030
14.7.1. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Scale of Operation
14.7.2. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Type of Biologic
14.7.3. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Therapeutic Area
14.7.4. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Geographical Region
14.7.4.1. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Scale of Operation
14.7.4.2. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Type of Biologic
14.7.4.3. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Therapeutic Area
14.7.4.4. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Scale of Operation
14.7.4.5. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Type of Biologic
14.7.4.6. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Therapeutic Area
14.7.4.7. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.7.4.8. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.7.4.9. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Therapeutic Area
14.8. Biologics Fill/Finish Services Market for Vials, 2019-2030
14.8.1. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Scale of Operation
14.8.2. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Type of Biologic
14.8.3. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Therapeutic Area
14.8.4. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Geographical Region
14.8.4.1. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Scale of Operation
14.8.4.2. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Type of Biologic
14.8.4.3. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Therapeutic Area
14.8.4.4. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Scale of Operation
14.8.4.5. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Type of Biologic
14.8.4.6. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Therapeutic Area
14.8.4.7. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Scale of Operation
14.8.4.8. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Type of Biologic
14.8.4.9. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Therapeutic Area

15. FUTURE GROWTH OPPORTUNITIES

15.1. Chapter Overview
15.2. Growing Biopharmaceutical Pipeline
15.3. Increase in Outsourcing Fill/Finish Activities
15.4. Rising Focus on Self-Administration
15.5. Advances in Aseptic Fill/Finish Technologies
15.6. Growing Opportunities in the Asia-Pacific Region

16. CASE STUDY: ROBOTIC SYSTEMS

IN FILL

/ FINISH OPERATIONS

16.1. Chapter Overview
16.2. Contract Service Providers: List of Fill/Finish Equipment
16.3. Role of Robotic Systems in Fill/Finish Operations
16.3.1. Types of Robots Used in Pharmaceutical Operations
16.3.2. Key Considerations for Selecting a Robotic System
16.3.3. Advantages of Robotic Systems
16.3.4. Disadvantages of Robotic Systems
16.4. Companies Providing Robots for Use in the Pharmaceutical Industry
16.5. Concluding Remarks

17. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS IN ASEPTIC FILL / FINISH OPERATIONS

17.1. Chapter Overview
17.2. Role of Ready-to-Use Packaging Components in Aseptic Fill/Finish Operations
17.2.1. Advantages of Ready-to-Use Packaging Components
17.2.2. Disadvantages of Ready-to-Use Packaging Components
17.3. Companies Providing Ready-to-Use Packaging Components
17.4. Concluding Remarks

18. CONCLUSION

18.1. Outsourcing of Drug Product Filling and Packaging Operations is Driven by the Growing Pipeline of Biologics and Biosimilars
18.2. The Contract Fill/Finish Services Landscape Features a Mix of Large and Mid-sized Players, Offering a Variety of Services for End-Stage Product Development
18.3 North America and Europe have Emerged as Key Hubs for Fill/Finish Services
18.4 Many Players have Entered into Strategic Collaborations and are Actively Expanding and Upgrading Their Existing Infrastructure to Enhance their Service Offerings and Drug Product Development Capabilities
18.5 To Cater to the Growing Demand for Fill/Finish Services, Many Players are Entering into Strategic Partnerships and Expanding / Upgrading Existing Infrastructure
18.6 As the Annual Demand for Fill/Finish of Biologics is Likely to Increase in Future, Service Providers will be Required to Invest in Additional Capacity
18.7 Given Existing Trends in Outsourcing Fill/Finish Operations, the Market is Anticipated to Witness Significant Growth in the Coming Decade

19. INTERVIEW TRANSCRIPTS

19.1 Chapter Overview
19.2 HALIX
19.2.1 Interview Transcript: Jos Vergeest, International Business Developer
19.3 IDT Biologika
19.3.1. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
19.4 oncomed manufacturing
19.4.1 Interview Transcript: Ales Sima, Business Development Manager
19.5. Syngene
19.5.1 Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development

20. APPENDIX 1: TABULATED DATA21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

Figure 3.1. Types of Biologics
Figure 3.2. Types of Third-Party Service Providers
Figure 3.3. Commonly Outsourced Operations
Figure 3.4. Steps Involved in Fill/Finish of Biologics
Figure 3.5. Key Considerations for Selecting a CMO Partner
Figure 3.6. Risks and Challenges Associated with Outsourcing Biologics Fill/Finish Operations
Figure 4.1. Biologics Fill/Finish Service Providers: Analysis by Year of Establishment
Figure 4.2. Biologics Fill/Finish Service Providers: Analysis by Company Size
Figure 4.3. Biologics Fill/Finish Service Providers: Analysis by Location of Headquarters
Figure 4.4. Biologics Fill/Finish Service Providers: Analysis by Location of Fill/Finish Facilities
Figure 4.5. Biologics Fill/Finish Service Providers: Analysis by Type of Packaging
Figure 4.6. Biologics Fill/Finish Service Providers: Analysis by Additional Services Offered
Figure 4.7. Biologics Fill/Finish Service Providers: Analysis by Scale of Operation
Figure 4.8. Biologics Fill/Finish Service Providers: Analysis by Type of Biologic
Figure 5.1. Competitiveness Analysis of Biologics Fill/Finish Service Providers in North America
Figure 5.2. Competitiveness Analysis of North American Companies Offering Fill/Finish Services for Ampoules
Figure 5.3. Competitiveness Analysis of North American Companies Offering Fill/Finish Services for Cartridges
Figure 5.4. Competitiveness Analysis of North American Companies Offering Fill/Finish Services for Syringes
Figure 5.5. Competitiveness Analysis of North American Companies Offering Fill/Finish Services for Vials
Figure 5.6. Competitiveness Analysis of Biologics Fill/Finish Service Providers in Europe
Figure 5.7. Competitiveness Analysis of European Service Providers Offering Fill/Finish for Ampoules
Figure 5.8. Competitiveness Analysis of European Service Providers Offering Fill/Finish for Cartridges
Figure 5.9. Competitiveness Analysis European Service Providers Offering Fill/Finish for Syringes
Figure 5.10. Competitiveness Analysis of European Service Providers Offering Fill/Finish for Vials
Figure 5.11. Competitiveness Analysis of Biologics Fill/Finish Service Providers in Asia-Pacific
Figure 5.12. Competitiveness Analysis of Asia-Pacific Service Providers Offering Fill/Finish for Ampoules
Figure 5.13. Competitiveness Analysis of Asia-Pacific Service Providers Offering Fill/Finish for Cartridges
Figure 5.14. Competitiveness Analysis of Asia-Pacific Service Providers Offering Fill/Finish for Syringes
Figure 5.15. Competitiveness Analysis of Asia-Pacific Service Providers Offering Fill/Finish for Vials
Figure 6.1. ABL: Overview of Service Portfolio
Figure 6.2. AMRI: Overview of Service Portfolio
Figure 6.3. AMRI: Annual Revenues, 2012- Q1 2017 (USD Million)
Figure 6.4. AMRI: Revenues by Business Divisions, 2016 (USD Million)
Figure 6.5. BioPharma Solutions: Overview of Service Portfolio
Figure 6.6. Baxter International: Annual Revenues, 2012 –2018 (USD Billion)
Figure 6.7. BioReliance: Overview of Service Portfolio
Figure 6.8. Merck KGaA: Annual Revenues, 2012 –2018 (USD Billion)
Figure 6.9. Merck KGaA: Annual Revenues by Business Sector, 2018 (EUR Billion)
Figure 6.10. Emergent BioSolutions: Overview of Service Portfolio
Figure 6.11. Emergent BioSolutions: Annual Revenues, 2012- 2018 (USD Million)
Figure 6.12. Emergent BioSolutions: Revenues of Contract Manufacturing Business Division, 2012-2018 (USD Million)
Figure 6.13. Patheon: Overview of Development Services Portfolio
Figure 6.14. Patheon: Overview of Development Services Portfolio
Figure 6.15. Thermo Fisher Scientific: Annual Revenues, 2012 – 2018 (USD Billion)
Figure 6.16. Patheon: Annual Revenues, 2012 – H1 2017 (USD Million)
Figure 6.17. Patheon: Revenues by Business Segments in 2016 (USD Million)
Figure 7.1. Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Figure 7.2. Boehringer Ingelheim: Annual Revenues, 2012- 2018 (EUR Billion)
Figure 7.3. IDT Biologika: Overview of Service Portfolio
Figure 7.4. Lonza: Overview of Service Portfolio
Figure 7.5. Lonza: Annual Revenues, 2012- 2018 (CHF Million)
Figure 7.6. Recipharm: Overview of Service Portfolio
Figure 7.7. Recipharm: Annual Revenues, 2012- 2018 (SEK Million)
Figure 7.8. Vetter Pharma: Overview of Service Portfolio
Figure 8.1. Biocon: Overview of Service Portfolio
Figure 8.2. Biocon: Annual Revenues, 2012-2018 (INR Billion)
Figure 8.3. Biocon: Revenues by Business Divisions, 2018 (INR Billion)
Figure 8.4. ChemPartner: Overview of Service Portfolio
Figure 8.5. LuinaBio: Overview of Service Portfolio
Figure 8.6. Mycenax Biotech: Overview of Service Portfolio
Figure 8.7. Mycenax Biotech: Annual Revenues, 2014-2018 (TWD Million)
Figure 8.8. WuXi Biologics: Overview of Service Portfolio
Figure 8.9. WuXi Biologics: Annual Revenues, 2014-2018 (RMB Million)
Figure 9.1. Partnerships and Collaborations: Distribution by Year, 2013-2019
Figure 9.2. Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3. Partnerships and Collaborations: Distribution by Type of Service
Figure 9.4. Partnerships and Collaborations: Distribution by Scale of Operation and Type of Service
Figure 9.5. Partnerships and Collaborations: Distribution by Type of Biologic and Type of Service
Figure 9.6. Partnerships and Collaborations: Distribution by Geographical Location
Figure 9.7. Partnerships and Collaborations: Most Active Players
Figure 9.8. Service Alliances and Supply Agreements: Distribution by Type of Service
Figure 9.9. Acquisitions and Mergers: Distribution by Type of Service
Figure 10.1. Expansions: Distribution by Year, 2013-2019
Figure 10.2. Expansions: Distribution by Type of Expansion
Figure 10.3. Expansions: Distribution by Type of Packaging
Figure 10.4. Expansions: Distribution by Type of Expansion and Type of Service
Figure 10.5. Expansions: Distribution by Type of Biologic
Figure 10.6. Expansions: Distribution by Geographical Location
Figure 10.7. Expansions: Distribution by Geography and Year, 2013-2019
Figure 10.8. Expansions: Distribution by Type of Biologic and Scale of Operation
Figure 10.9. Expansions: Most Active Players
Figure 10.10. Expansions in North America: Distribution by Type of Service and Type of Biologic
Figure 10.11. Expansions in Europe: Distribution by Type of Service and Type of Biologic
Figure 10.12. Expansions in Asia Pacific: Distribution by Type of Service and Type of Biologic
Figure 11.1. Biologics Fill/Finish Service Providers for Ampoules: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Figure 11.2. Biologics Fill/Finish Service Providers for Cartridges: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Figure 11.3. Biologics Fill/Finish Service Providers for Syringes: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Figure 11.4. Biologics Fill/Finish Service Providers for Vials: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Figure 11.5. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Type of Packaging (Million)
Figure 11.6. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Size of Manufacturer (Million)
Figure 11.7. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Scale of Operation (Million)
Figure 11.8. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Location of Headquarters (Million)
Figure 11.9. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Figure 11.10. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Type of Packaging (Liters)
Figure 11.11. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Size of Manufacturer (Liters)
Figure 11.12. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Scale of Operation (Liters)
Figure 11.13. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Location of Headquarters (Liters)
Figure 11.14. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.15. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Size of Manufacturer (Million)
Figure 11.16. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Range of Capacity by Size of Manufacturer (Million)
Figure 11.17. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Scale of Operation (Million)
Figure 11.18. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Location of Headquarters (Million)
Figure 11.19. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Figure 11.20. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Distribution by Size of Manufacturer (Liters)
Figure 11.21. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Range of Capacity by Size of Manufacturer (Liters)
Figure 11.22. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Distribution by Scale of Operation (Liters)
Figure 11.23. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Distribution by Location of Headquarters (Liters)
Figure 11.24. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.25. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Size of Manufacturer (Million)
Figure 11.26. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Range of Capacity by Size of Manufacturer (Million)
Figure 11.27. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Scale of Operation (Million)
Figure 11.28. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Location of Headquarters (Million)
Figure 11.29. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Figure 11.30. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Distribution by Size of Manufacturer (Liters)
Figure 11.31. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Range of Capacity by Size of Manufacturer (Liters)
Figure 11.32. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Distribution by Scale of Operation (Liters)
Figure 11.33. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Distribution by Location of Headquarters (Liters)
Figure 11.34. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.35. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Size of Manufacturer (Million)
Figure 11.36. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Range of Capacity by Size of Manufacturer (Million)
Figure 11.37. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Scale of Operation (Million)
Figure 11.38. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Location of Headquarters (Million)
Figure 11.39. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Figure 11.40. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Distribution by Size of Manufacturer (Liters)
Figure 11.41. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Range of Capacity by Size of Manufacturer (Liters)
Figure 11.42. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Distribution by Scale of Operation (Liters)
Figure 11.43. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Distribution by Location of Headquarters (Liters)
Figure 11.44. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.45. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Size of Manufacturer (Million)
Figure 11.46. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Range of Capacity by Size of Manufacturer (Million)
Figure 11.47. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Scale of Operation (Million)
Figure 11.48. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Location of Headquarters (Million)
Figure 11.49. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Figure 11.50. Global Biologics Fill/Finish Capacity for Vials (by Volume): Distribution by Size of Manufacturer (Liters)
Figure 11.51. Global Biologics Fill/Finish Capacity for Vials (by Volume): Range of Capacity by Size of Manufacturer (Liters)
Figure 11.52. Global Biologics Fill/Finish Capacity for Vials (by Volume): Distribution by Scale of Operation (Liters)
Figure 11.53. Global Biologics Fill/Finish Capacity for Vials (by Volume): Distribution by Location of Headquarters (Liters)
Figure 11.54. Global Biologics Fill/Finish Capacity for Vials (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.55. Biologics Fill/Finish Service Providers: Distribution of Global Capacity by Location of Fill/Finish Facilities
Figure 11.56. Biologics Fill/Finish Service Providers: Distribution of Global Capacity by Packaging Form and Size of Service Provider
Figure 12.1. Global Demand for Biologics Fill/Finish Services
Figure 12.2. Global Demand for Biologics Fill/Finish Services: Distribution by Type of Packaging
Figure 12.3. Global Demand for Biologics Fill/Finish Services: Distribution by Scale of Operation
Figure 12.4. Global Demand for Biologics Fill/Finish Services: Distribution by Type of Biologic
Figure 12.5. Global Demand for Biologics Fill/Finish Services: Distribution by Therapeutic Area
Figure 12.6. Global Demand for Biologics Fill/Finish Services: Distribution by Geographical Location
Figure 12.7. Global Biologics Fill/Finish Services: Demand and Supply
Figure 13.1. Biologics Fill/Finish Service Providers: Key Performance Indicators (KPIs)
Figure 13.2. Financial Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.3. Financial Indicators: Big Pharma Perspective
Figure 13.4. Financial Indicators: Contract Manufacturers’ Perspective
Figure 13.5. Process / Capability Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.6. Process / Capability Indicators: Big Pharma Perspective
Figure 13.7. Process / Capability Indicators: Contract Manufacturers’ Perspective
Figure 13.8. Market Reputation Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.9. Market Reputation Indicators: Big Pharma Perspective
Figure 13.10. Market Reputation Indicators: Contract Manufacturers’ Perspective
Figure 14.1. Overall Biologics Fill/Finish Services Market, 2019-2030 (USD Billion)
Figure 14.2. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Type of Packaging (USD Billion)
Figure 14.3. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Scale of Operation (USD Billion)
Figure 14.4. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Type of Biologic (USD Billion)
Figure 14.5. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Therapeutic Area (USD Billion)
Figure 14.6. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Geographical Region (USD Billion)
Figure 14.7. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Type of Packaging (USD Billion)
Figure 14.8. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Scale of Operation (USD Billion)
Figure 14.9. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Type of Biologic (USD Billion)
Figure 14.10. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Therapeutic Area (USD Billion)
Figure 14.11. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Type of Packaging (USD Billion)
Figure 14.12. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Scale of Operation (USD Billion)
Figure 14.13. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Type of Biologic (USD Billion)
Figure 14.14. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Therapeutic Area (USD Billion)
Figure 14.15. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Type of Packaging (USD Billion)
Figure 14.16. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Scale of Operation (USD Billion)
Figure 14.17. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Type of Biologic (USD Billion)
Figure 14.18. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Therapeutic Area (USD Billion)
Figure 14.19. Biologics Fill/Finish Services Market for Ampoules, 2019-2030 (USD Million)
Figure 14.20. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.21. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.22. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.23. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Geographical Region (USD Million)
Figure 14.24. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.25. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.26. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.27. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.28. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.29. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.30. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.31. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.32. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.33. Biologics Fill/Finish Services Market for Cartridges, 2019-2030 (USD Million)
Figure 14.34. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.35. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.36. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.37. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Geographical Region (USD Million)
Figure 14.38. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.39. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.40. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.41. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.42. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.43. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.44. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.45. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.46. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.47. Biologics Fill/Finish Services Market for Syringes, 2019-2030 (USD Million)
Figure 14.48. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.49. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.50. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.51. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Geographical Region (USD Million)
Figure 14.52. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.53. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.54. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.55. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.56. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.57. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.58. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.59. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.60. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.61. Biologics Fill/Finish Services Market for Vials, 2019-2030 (USD Million)
Figure 14.62. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.63. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.64. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.65. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Geographical Region (USD Million)
Figure 14.66. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.67. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.68. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.69. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.70. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.71. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 14.72. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Scale of Operation (USD Million)
Figure 14.73. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Type of Biologic (USD Million)
Figure 14.74. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Therapeutic Area (USD Million)
Figure 15.1. Growth Opportunities for Biologics Fill/Finish Service Providers
Figure 15.2. New Molecular Entities Approved by the FDA, 2011-2018
Figure 16.1. Key Considerations for Selecting a Robotic System
Figure 16.2. Advantages of Robotic Systems in Pharmaceutical Operations
Figure 17.1. Drivers of Ready-to-Use Platform
Figure 18.1. Overall Biologics Fill/Finish Services Market, 2020, 2025 and 2030: Conservative, Base and Optimistic Scenarios

List of Tables

Table 3.1. Best-Selling Drugs of 2018
Table 4.1. Biologics Fill/Finish Service Providers: List of Companies
Table 4.2. Biologics Fill/Finish Service Providers: Information on Type of Packaging
Table 4.3. Biologics Fill/Finish Service Providers: Information on Additional Services Offered
Table 4.4. Biologics Fill/Finish Service Providers: Information on Scale of Operation
Table 4.5. Biologics Fill/Finish Service Providers: Information on Type of Biologic
Table 4.6. Biologics Fill/Finish Service Providers: Information on Fill/Finish Capability
Table 6.1. Biologics Fill/Finish Service Providers in North America: List of Profiled Companies
Table 6.2. ABL: Company Overview
Table 6.3. ABL: Overview of Drug Product Solutions
Table 6.4. ABL: Sterile Manufacturing Facilities
Table 6.5. ABL: Future Outlook
Table 6.6. AMRI: Company Overview
Table 6.7. AMRI: Overview of Drug Product Solutions
Table 6.8. AMRI: Sterile Manufacturing Facilities
Table 6.9. AMRI: Future Outlook
Table 6.10. BioPharma Solutions: Company Overview
Table 6.11. BioPharma Solutions: Overview of Drug Product Solutions
Table 6.12. BioPharma Solutions: Sterile Manufacturing Facilities
Table 6.13. BioPharma Solutions: Future Outlook
Table 6.14. BioReliance: Company Overview
Table 6.15. BioReliance: Overview of Drug Product Solutions
Table 6.16. BioReliance: Sterile Manufacturing Facilities
Table 6.17. BioReliance (MilliporeSigma): Future Outlook
Table 6.18. Emergent BioSolutions: Company Overview
Table 6.19. Emergent BioSolutions: Overview of Drug Product Solutions
Table 6.20. Emergent BioSolutions: Sterile Manufacturing Facilities
Table 6.21. Emergent BioSolutions: Future Outlook
Table 6.22. Patheon: Company Overview
Table 6.23. Patheon: Overview of Drug Product Solutions
Table 6.24. Patheon: Sterile Manufacturing Facilities
Table 6.25. Patheon: Future Outlook
Table 7.1. Biologics Fill/Finish Service Providers in Europe: List of Profiled Companies
Table 7.2. Boehringer Ingelheim BioXcellence: Company Overview
Table 7.3. Boehringer Ingelheim BioXcellence: Overview of Drug Product Solutions
Table 7.4. Boehringer Ingelheim BioXcellence: Sterile Manufacturing Facilities
Table 7.5. Boehringer Ingelheim BioXcellence: Future Outlook
Table 7.6. IDT Biologika: Company Overview
Table 7.7. IDT Biologika: Overview of Drug Product Solutions
Table 7.8. IDT Biologika: Future Outlook
Table 7.9. Lonza: Company Overview
Table 7.10. Lonza: Overview of Drug Product Solutions
Table 7.11. Lonza: Future Outlook
Table 7.12. Recipharm: Company Overview
Table 7.13. Recipharm: Overview of Drug Product Solutions
Table 7.14. Recipharm: Sterile Manufacturing Facilities
Table 7.15. Recipharm: Future Outlook
Table 7.16. Vetter Pharma: Company Overview
Table 7.17. Vetter Pharma: Overview of Drug Product Solutions
Table 7.18. Vetter Pharma: Future Outlook
Table 8.1. Biologics Fill/Finish Service Providers in Asia-Pacific: List of Profiled Companies
Table 8.2. Biocon: Company Overview
Table 8.3. Biocon: Overview of Drug Product Solutions
Table 8.4. Biocon: Future Outlook
Table 8.5. ChemPartner: Company Overview
Table 8.6. ChemPartner: Overview of Drug Product Solutions
Table 8.7. ChemPartner: Future Outlook
Table 8.8. LuinaBio: Company Overview
Table 8.9. LuinaBio: Overview of Drug Product Solutions
Table 8.10. LuinaBio: Future Outlook
Table 8.11. Mycenax Biotech: Company Overview
Table 8.12. Mycenax Biotech: Overview of Drug Product Solutions
Table 8.13. Mycenax Biotech: Future Outlook
Table 8.14. WuXi Biologics: Company Overview
Table 8.15. WuXi Biologics: Overview of Drug Product Solutions
Table 8.16. WuXi Biologics: Sterile Manufacturing Facilities
Table 8.17. WuXi Biologics: Future Outlook
Table 9.1. Biologics Fill/Finish Service Providers: Partnerships and Collaborations, 2013-2019
Table 9.2. Partnerships and Collaborations: Information on Types of Biologics, 2013-2019
Table 9.3. Service Alliances and Supply Agreements: Information on Types of Services
Table 9.4. Acquisitions and Mergers: Information on Types of Services
Table 10.1. Biologics Fill/Finish Service Providers: Recent Expansions, 2013-2019
Table 10.2. Expansions: Information on Types of Packaging
Table 10.3. Expansions: Information on Types of Services
Table 10.4. Expansions: Information on Types of Biologics
Table 11.1. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Average Capacity by Size of Manufacturer (Sample Data Set)
Table 11.2. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Average Capacity by Size of Manufacturer (Sample Data Set)
Table 11.3. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Average Capacity by Size of Manufacturer (Sample Data Set)
Table 11.4. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Average Capacity by Size of Manufacturer (Sample Data Set)
Table 11.5. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Size of Manufacturer
Table 11.6. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Size of Manufacturer
Table 11.7. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Size of Manufacturer
Table 11.8. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Size of Manufacturer
Table 15.1. Patent Expiry of Biologics, 2018-2023
Table 16.1. Biologics Fill/Finish Service Providers: Information on Fill/Finish Equipment Used
Table 16.2. List of Pharmaceutical Robotics Manufacturers
Table 17.1. List of Companies Supplying Ready-to-Use Packaging Components
Table 20.1. Biologics Fill/Finish Service Providers: Analysis by Year of Establishment
Table 20.2. Biologics Fill/Finish Service Providers: Analysis by Company Size
Table 20.3. Biologics Fill/Finish Service Providers: Analysis by Location of Headquarters
Table 20.4. Biologics Fill/Finish Service Providers: Analysis by Location of Fill/Finish Facilities
Table 20.5. Biologics Fill/Finish Service Providers: Analysis by Type of Packaging
Table 20.6. Biologics Fill/Finish Service Providers: Analysis by Type of Additional Services Offered
Table 20.7. Biologics Fill/Finish Service Providers: Analysis by Scale of Operation
Table 20.8. Biologics Fill/Finish Service Providers: Analysis by Type of Biologic
Table 20.9. AMRI: Annual Revenues, 2012- Q1 2017 (USD Million)
Table 20.10. AMRI: Revenues by Business Divisions, 2016 (USD Million)
Table 20.11. Baxter International: Annual Revenues, 2012 –2018 (USD Billion)
Table 20.12. Merck KGaA: Annual Revenues, 2012 –2018 (USD Billion)
Table 20.13. Merck KGaA: Annual Revenues by Business Sector, 2018 (EUR Billion)
Table 20.14. Emergent BioSolutions: Annual Revenues, 2012- 2018 (USD Million)
Table 20.15. Emergent BioSolutions: Revenues of Contract Manufacturing Business Division, 2012-2018 (USD Million)
Table 20.16. Thermo Fisher Scientific: Annual Revenues, 2012 – 2018 (USD Billion)
Table 20.17. Patheon: Annual Revenues, 2012 – H1 2017 (USD Million)
Table 20.18. Patheon: Revenues by Business Segments in 2016 (USD Million)
Table 20.19. Boehringer Ingelheim: Annual Revenues, 2012- 2018 (EUR Billion)
Table 20.20. Lonza: Annual Revenues, 2012- 2018 (CHF Million)
Table 20.21. Recipharm: Annual Revenues, 2012- 2018 (SEK Million)
Table 20.22. Biocon: Annual Revenues, 2012-2018 (INR Billion)
Table 20.23. Biocon: Revenues by Business Divisions, 2018 (INR Billion)
Table 20.24. Mycenax Biotech: Annual Revenues, 2014-2018 (TWD Million)
Table 20.25. WuXi Biologics: Annual Revenues, 2014-2018 (RMB Million)
Table 20.26. Partnerships and Collaborations: Distribution by Year, 2013-2019
Table 20.27. Partnerships and Collaborations: Distribution by Type of Partnership
Table 20.28. Partnerships and Collaborations: Distribution by Type of Service
Table 20.29. Partnerships and Collaborations: Distribution by Scale of Operation and Type of Service
Table 20.30. Partnerships and Collaborations: Distribution by Type of Biologic and Type of Service
Table 20.31. Partnerships and Collaborations: Distribution by Geographical Location
Table 20.32. Partnerships and Collaborations: Most Active Players
Table 20.33. Service Alliances and Supply Agreements: Distribution by Types of Service
Table 20.34. Acquisitions and Mergers: Distribution by Types of Service
Table 20.35. Expansions: Distribution by Year, 2013-2019
Table 20.36. Expansions: Distribution by Type of Expansion
Table 20.37. Expansions: Distribution by Type of Packaging
Table 20.38. Expansions: Distribution by Type of Expansion and Type of Service
Table 20.39. Expansions: Distribution by Type of Biologic
Table 20.40. Expansions: Distribution by Geographical Location
Table 20.41. Expansions: Distribution by Type of Biologic and Scale of Operation
Table 20.42. Expansions: Most Active Players
Table 20.43. Expansions in North America: Distribution by Type of Service and Type of Biologic
Table 20.44. Expansions in Europe: Distribution by Type of Service and Type of Biologic
Table 20.45. Expansions in Asia Pacific: Distribution by Type of Service and Type of Biologic
Table 20.46. Biologics Fill/Finish Service Providers for Ampoules: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Table 20.47. Biologics Fill/Finish Service Providers for Cartridges: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Table 20.48. Biologics Fill/Finish Service Providers for Syringes: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Table 20.49. Biologics Fill/Finish Service Providers for Vials: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
Table 20.50. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Type of Packaging (Million)
Table 20.51. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Size of Manufacturer (Million)
Table 20.52. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Scale of Operation (Million)
Table 20.53. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Location of Headquarters (Million)
Table 20.54. Global Biologics Fill/Finish Capacity (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Table 20.55. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Type of Packaging (Liters)
Table 20.56. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Size of Manufacturer (Liters)
Table 20.57. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Scale of Operation (Liters)
Table 20.58. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Location of Headquarters (Liters)
Table 20.59. Global Biologics Fill/Finish Capacity (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 20.60. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Size of Manufacturer (Million)
Table 20.61. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Range of Capacity by Size of Manufacturer (Million)
Table 20.62. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Scale of Operation (Million)
Table 20.63. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Location of Headquarters (Million)
Table 20.64. Global Biologics Fill/Finish Capacity for Ampoules (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Table 20.65. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Distribution by Size of Manufacturer (Liters)
Table 20.66. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Range of Capacity by Size of Manufacturer (Liters)
Table 20.67. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Distribution by Scale of Operation (Liters)
Table 20.68. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Distribution by Location of Headquarters (Liters)
Table 20.69. Global Biologics Fill/Finish Capacity for Ampoules (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 20.70. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Size of Manufacturer (Million)
Table 20.71. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Range of Capacity by Size of Manufacturer (Million)
Table 20.72. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Scale of Operation (Million)
Table 20.73. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Location of Headquarters (Million)
Table 20.74. Global Biologics Fill/Finish Capacity for Cartridges (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Table 20.75. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Distribution by Size of Manufacturer (Liters)
Table 20.76. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Range of Capacity by Size of Manufacturer (Liters)
Table 20.77. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Distribution by Scale of Operation (Liters)
Table 20.78. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Distribution by Location of Headquarters (Liters)
Table 20.79. Global Biologics Fill/Finish Capacity for Cartridges (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 20.80. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Size of Manufacturer (Million)
Table 20.81. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Range of Capacity by Size of Manufacturer (Million)
Table 20.82. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Scale of Operation (Million)
Table 20.83. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Location of Headquarters (Million)
Table 20.84. Global Biologics Fill/Finish Capacity for Syringes (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Table 20.85. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Distribution by Size of Manufacturer (Liters)
Table 20.86. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Range of Capacity by Size of Manufacturer (Liters)
Table 20.87. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Distribution by Scale of Operation (Liters)
Table 20.88. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Distribution by Location of Headquarters (Liters)
Table 20.89. Global Biologics Fill/Finish Capacity for Syringes (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 20.90. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Size of Manufacturer (Million)
Table 20.91. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Range of Capacity by Size of Manufacturer (Million)
Table 20.92. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Scale of Operation (Million)
Table 20.93. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Location of Headquarters (Million)
Table 20.94. Global Biologics Fill/Finish Capacity for Vials (by Number of Units): Distribution by Location of Fill/Finish Facilities (Million)
Table 20.95. Global Biologics Fill/Finish Capacity for Vials (by Volume): Distribution by Size of Manufacturer (Liters)
Table 20.96. Global Biologics Fill/Finish Capacity for Vials (by Volume): Range of Capacity by Size of Manufacturer (Liters)
Table 20.97. Global Biologics Fill/Finish Capacity for Vials (by Volume): Distribution by Scale of Operation (Liters)
Table 20.98. Global Biologics Fill/Finish Capacity for Vials (by Volume): Distribution by Location of Headquarters (Liters)
Table 20.99. Global Biologics Fill/Finish Capacity for Vials (by Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 20.100. Biologics Fill/Finish Service Providers: Distribution of Global Capacity by Location of Fill/Finish Facilities
Table 20.101. Biologics Fill/Finish Service Providers: Distribution of Global Capacity by Packaging Form and Size of Service Provider
Table 20.102. Global Demand for Biologics Fill/Finish Services
Table 20.103. Global Demand for Biologics Fill/Finish Services: Distribution by Type of Packaging
Table 20.104. Global Demand for Biologics Fill/Finish Services: Distribution by Scale of Operation
Table 20.105. Global Demand for Biologics Fill/Finish Services: Distribution by Type of Biologic
Table 20.106. Global Demand for Biologics Fill/Finish Services: Distribution by Therapeutic Area
Table 20.107. Global Demand for Biologics Fill/Finish Services: Distribution by Geographical Location
Table 20.108. Overall Biologics Fill/Finish Services Market, 2019-2030: Distribution by Type of Packaging, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.109. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.110. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.111. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.112. Biologics Fill/Finish Services Market, 2019-2030: Distribution by Geographical Region, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.113. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Type of Packaging, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.114. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.115. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.116. Biologics Fill/Finish Services Market in North America, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.117. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Type of Packaging, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.118. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.119. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.120. Biologics Fill/Finish Services Market in Europe, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.121. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Type of Packaging, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.122. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.123. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.124. Biologics Fill/Finish Services Market in Asia Pacific, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 20.125. Biologics Fill/Finish Services Market for Ampoules, 2019-2030 (USD Million): Conservative, Base and Optimistic Scenarios
Table 20.126. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.127. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.128. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.129. Biologics Fill/Finish Services Market for Ampoules, 2019-2030: Distribution by Geographical Region, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.130. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.131. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.132. Biologics Fill/Finish Services Market for Ampoules in North America, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.133. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.134. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.135. Biologics Fill/Finish Services Market for Ampoules in Europe, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.136. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.137. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.138. Biologics Fill/Finish Services Market for Ampoules in Asia Pacific, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.139. Biologics Fill/Finish Services Market for Cartridges, 2019-2030 (USD Million): Conservative, Base and Optimistic Scenarios
Table 20.140. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.141. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.142. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.143. Biologics Fill/Finish Services Market for Cartridges, 2019-2030: Distribution by Geographical Region, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.144. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.145. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.146. Biologics Fill/Finish Services Market for Cartridges in North America, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.147. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.148. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.149. Biologics Fill/Finish Services Market for Cartridges in Europe, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.150. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.151. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.152. Biologics Fill/Finish Services Market for Cartridges in Asia Pacific, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.153. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.154. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.155. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.156. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.157. Biologics Fill/Finish Services Market for Syringes, 2019-2030: Distribution by Geographical Region, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.158. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.159. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.160. Biologics Fill/Finish Services Market for Syringes in North America, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.161. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.162. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.163. Biologics Fill/Finish Services Market for Syringes in Europe, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.164. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.165. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.166. Biologics Fill/Finish Services Market for Syringes in Asia Pacific, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.167. Biologics Fill/Finish Services Market for Vials, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.168. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.169. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.170. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.171. Biologics Fill/Finish Services Market for Vials, 2019-2030: Distribution by Geographical Region, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.172. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.173. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.174. Biologics Fill/Finish Services Market for Vials in North America, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.175. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.176. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.177. Biologics Fill/Finish Services Market for Vials in Europe, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.178. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.179. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Type of Biologic, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.180. Biologics Fill/Finish Services Market for Vials in Asia Pacific, 2019-2030: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.181. Overall Biologics Fill/Finish Services Market, 2020, 2025 and 2030: Conservative, Base and Optimistic Scenarios

Companies Mentioned

AMRI
APG Europe
ARaymond Life
AbbVie
Adimmune
Advanced BioScience Laboratories
Afton Scientific
Agilis Biotherapeutics
Ajinomoto Bio-Pharma Services
Akron Biotech
Alcami
Alcon
Allergy Laboratories
Amatsigroup
Amgen
Amicus Therapeutics
Anchiano Therapeutics
Apceth Biopharma
Aptar Pharma
Aptuit
Arabio
Arch Biopartners
Aseptic Technologies
Austrianova
Axcellerate Pharma
BAUSCH Advanced Technology Group
Baccinex
Bausch & Ströbel
Baxter
Bayer
Becton Dickinson
Bio Elpida
Bio-Concept Laboratories
BioConnection
BioMARC
BioPharma Solutions
BioReliance
BioTechLogic
BioTechnique
Biocon
Biofabri
Biogen
Biomedical Advanced Research and Development Authority
Biotechpharma
Biovian
Boehringer Ingelheim BioXcellence
Bosch Packaging Technology
Brammer Bio
Bristol-Myers Squibb
Bryllan
Burrard Pharmaceuticals
CARBOGEN AMCIS
CMC Biologics
Canada Peptide
Cangene
Capmatic
Catalent Biologics
Celgene
Cell Culture Company
Cellin Technologies
Celonic
Cenexi
Cerbios-Pharma
Cerium Pharmaceuticals
Chase-Logeman
China Gateway Biologics
CinnaGen
Cobra Biologics
Coldstream Laboratories
Cook Pharmica
CordenPharma
Cozzoli Machine Company
Cytovance Biologics
DM Bio
DSM Pharmaceutical Products
DWK Life Sciences
Daikyo Seiko
Dalton Pharma Services
Datwyler Group
Dr. Reddy's Custom Pharma Services
EMA Pharmaceuticals
EUCODIS Bioscience
EVER Pharma
EirGen Pharma
Emergent BioSolutions
EuBiologics
Eurofins Scientific
Exelead
FUJIFILM Diosynth Biotechnologies
Fresenius Kabi Contract Manufacturing
GLyPharma (acquired by Therachon)
GTCR
Gadea Pharmaceutical (acquired by AMRI)
GenIbet Biopharmaceuticals
Genentech
Generic Specialities
Gerresheimer
GlaxoSmithKline
Goodwin Biotechnology
Grand River Aseptic Manufacturing
Gröninger
HALIX
HOOKIPA Pharma
Hameln Pharmaceuticals
Health Biotech
Hepalink USA
Hisun Pharmaceuticals USA
Hitachi Chemical Advanced Therapeutics Solutions
Hycult Biotech
IDT Biologika
IMA Group
Immune Pharmaceuticals
Infectious Disease Research Institute
Intas Pharmaceuticals
Integrity Bio
JHL Biotech
Johnson & Johnson
Jubilant HollisterStier
KABS Pharmaceutical Services
Kaysersberg Pharmaceuticals (acquired by Recipharm)
Kemwell Biopharma
Kyowa Hakko Kirin
LSNE Contract Manufacturing
Lonza
LuinaBio
Lyophilization Technology
M&O Perry
MabPlex
Madison Dearborn Partners
MassBiologics
Merck
Microdermics
Millmount Healthcare (acquired by PCI Services)
Miltenyi Biotec
Morgridge Institute for Research
Mycenax Biotech
Najít Technologies
National Institutes of Health
Ningbo Zhengli Pharmaceutical Packing
Nipro PharmaPackaging
Nitto Avecia Pharma Services
Nitto Denko Avecia
Nova Laboratories
Novartis
Novasep
OPKO Health
OPTIMA pharma
Ompi
Oncomed manufacturing
Oncotec Pharma Produktion
Oryn Therapeutics
Oso BioPharmaceutical Manufacturing
Ottawa Hospital Research Institute
PCI Pharma Services
PCT
PSC Biotech
PYRAMID Laboratories
Pall Life Sciences
Panacea Pharmaceuticals
Paragon Bioservices
Partners Group
Patheon
Penn Pharmaceutical Services
Permira
Pfizer
Pharmaceutical Packaging Professionals
Pierre Fabre
Piramal Pharma Solutions
Polpharma Biologics
Polymun Scientific
Praxis Pharmaceutical
PrimaPharma
Prince Sterilization Services
Quality BioResources
ROTA Verpackungstechnik
Recipharm
Regeneron Pharmaceuticals
Reliance Life Sciences
Rentschler Biotechnologie
Rentschler Fill Solutions
Roche
Rommelag CMO
RoslinCT
SAFC
SCHOTT
SIRION Biotech
SME Biotech Consulting
Samsung BioLogics
Samsung Bioepis
Sanofi
Saudi Biotechnology Manufacturing
Selecta Biosciences
Shenzhen Hepalink Pharmaceutical
Sherpa Clinical Packaging (acquired by PCI Pharma Services)
SiO2 Medical Products
SialoCarb
Siegfried Holding
Singota Solutions
Stevanato Group
Swissfillon
Symbiosis Pharmaceutical Services
Symphogen
Syngene
Sypharma
Tanvex BioPharma
The Carlyle Group
Therapure Biomanufacturing
Thermo Fisher Scientific
Transcoject
Ultragenyx Pharmaceutical
VGXI
Vanrx Pharmasystems
Vetter Pharma
Vibalogics
Vigene Biosciences
Waisman Biomanufacturing
Watson-Marlow Fluid Technology Group
West Pharmaceutical Services
WuXi Biologics
Wuxi Fortune Pharmaceutical
Wuxi Griffin Pharmaceuticals
Yposkesi

Methodology

LOADING...

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4370EUR$4,499USD£3,733GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€7769EUR$7,999USD£6,637GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€15539EUR$15,999USD£13,275GBP

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Global Biopharmaceuticals Contract Manufacturing Market by Product (Biologics, Biosimilar), Source (Mammalian, Microbial-Based Biologics or Non-Mammalian), Contract Type, Service, Scale of Operation, Therapeutic Applications - Forecast 2024-2030

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

Biologics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Single Use Bioreactors Market (3rd Edition) - Distribution by Type of Bioreactor, Scale of Operation, Type of Cell Culture, Type of Biologics Synthesized, Application Area, End-users, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

Global Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030